Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

Trending With Impact: New Pre-Transplant AML Treatment Combinations

Oncotarget

February 17, 2022
Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant treatment combinations. continue reading »

Behind the Study: Oncogenic Transformation and Iron Chelation

Oncotarget

February 7, 2022
Drs. Stephany Veuger and Gina Abdelaal from Northumbria University describe their 2021 review paper published by Oncotarget, entitled, "Reversing oncogenic transformation with iron chelation." continue reading »

Trending With Impact: What Causes Chemo Brain?

Oncotarget

January 27, 2022
Researchers investigated potential therapeutic culprits of “chemo brain” in a trending new paper published by Oncotarget. continue reading »

Prognostic Markers Identified in Ultra-Rare Adrenal Cancer

Oncotarget

January 26, 2022
Researchers demonstrated the overexpression of the protein APOBEC3B in adrenocortical carcinoma. They also identified the transcription factor, known as GATA3, that directly regulates APOBEC3B. continue reading »